Biomarkers As A Guide To Therapy In Heart Failure Patients
Sunday, February 1, 2009 - 23:28
in Health & Medicine
A randomized trial suggests that, while using BNP as a marker to guide therapy is not associated with any improvement in all-cause outcome over conventional symptom-guided therapy, there is indeed a benefit in hospital-free survival in heart failure patients under the age of 75.
Read the whole article on Science Daily
More from Science Daily
Related
- Biomarkers as a guide to therapy in heart failure patientsTue, 27 Jan 2009, 16:22:18 EST
- Using heart biomarker levels to guide therapy does not improve outcomes for heart failure patientsTue, 27 Jan 2009, 16:22:25 EST
- Exercise plus psychological counseling may benefit depressed heart failure patientsFri, 2 May 2008, 16:35:14 EDT
- Exercise is safe, improves quality of life in patients with chronic heart failureTue, 7 Apr 2009, 17:22:49 EDT
- First gene therapy for heart failure offered at NewYork-Presbyterian/ColumbiaWed, 18 Jun 2008, 15:21:40 EDT